The stock is in a powerful, sustained uptrend, evidenced by a staggering 1-year price change of +443.98%. With a current price of $158.46, it is trading near the top of its 52-week range, at approximately 95% of the distance between its 52-week low of $25.56 and high of $165.99, indicating extreme momentum but also raising concerns about potential overextension. Recent momentum has accelerated dramatically, with a 1-month surge of +65.89% and a 3-month gain of +149.03%, far outpacing the broader market's performance (SPY +4.84% and +8.15% respectively) and signaling a parabolic move likely driven by a fundamental catalyst. Key technical support now resides near the recent pre-surge levels around $95, while immediate resistance is at the 52-week high of $165.99; a decisive breakout above this level could signal a continuation of the rally, though the stock's high beta of 1.423 indicates it is approximately 42% more volatile than the market, which necessitates careful risk management given the extreme short-term gains.

Revenue growth is robust and accelerating, with Q4 2025 revenue of $242.39 million representing an 18.3% year-over-year increase, and sequential quarterly revenue has climbed consistently from $210.7 million in Q1 to the Q4 figure, indicating strong demand momentum. The company is profitable, posting Q4 net income of $25.66 million with a healthy gross margin of 58.7%, and operating margins have shown improvement, with the Q4 operating margin at 16.0% compared to 6.2% in Q1 2024, demonstrating effective scaling. The balance sheet shows a negative debt-to-equity ratio of -25.46, which is an accounting artifact typically stemming from an accumulated deficit (negative shareholder equity), but the company generates positive operating cash flow ($57.28 million in Q4) and has a trailing twelve-month free cash flow of $37.0 million, providing internal funding for its aggressive growth initiatives.